| Q34688754 | A kinetic study of sulindac in the elderly |
| Q35956848 | Acyl glucuronides revisited: is the glucuronidation process a toxification as well as a detoxification mechanism? |
| Q41217588 | Chirality and nonsteroidal anti-inflammatory drugs |
| Q38730316 | Clinical pharmacokinetic considerations in the elderly. An update |
| Q69018946 | Clinical pharmacokinetics of ketoprofen after single intravenous administration as a bolus or infusion |
| Q37950598 | Clinical pharmacokinetics of ketoprofen and its enantiomers |
| Q39521963 | Clinical pharmacology of NSAIDs |
| Q67969797 | Comparison of paracetamol metabolism in young adult and elderly males |
| Q39522004 | Drug metabolism in the elderly |
| Q38018026 | Hepatic drug metabolism and aging |
| Q77129794 | Human variability in glucuronidation in relation to uncertainty factors for risk assessment |
| Q35825392 | Influence of age on the enantiomeric disposition of ibuprofen in healthy volunteers |
| Q34182286 | Ketoprofen: a review of its pharmacologic and clinical properties |
| Q36282905 | Non-steroidal Anti-inflammatory Drugs: Monitoring to help prevent serious adverse effects |
| Q39560493 | Novel non-steroidal anti-inflammatory drugs |
| Q40425454 | Pharmacokinetic Optimisation of Drug Therapy in Elderly Patients |
| Q34447006 | Pharmacokinetic profile of controlled release ketoprofen in elderly patients |
| Q68372040 | Pharmacokinetics of Ketoprofen Enantiomers in Young and Elderly Arthritic Patients following Single and Multiple Doses |
| Q39654269 | Pharmacokinetics of enantiomers of chiral non-steroidal anti-inflammatory drugs |
| Q70743653 | Pharmacokinetics of indomethacin in the elderly |
| Q45008996 | Pharmacokinetics of ketoprofen in rats: effect of age and dose |
| Q69316438 | Pharmacokinetics of naproxen in elderly patients |
| Q39560470 | Pharmacokinetics of non-steroidal anti-inflammatory drugs |
| Q40809380 | Pharmacokinetics of reversible metabolic systems |
| Q44728643 | Plasma tenoxicam concentrations after single and multiple oral doses |
| Q41861859 | Reduced elimination of ketoprofen in the elderly is not necessarily due to impaired glucuronidation |
| Q40816610 | Rheumatoid arthritis in the aged. Incidence and optimal management |
| Q77762657 | Simultaneous analysis of 14 non-steroidal anti-inflammatory drugs in human serum by electrospray ionization-tandem mass spectrometry without chromatography |
| Q68047183 | Single and multiple dose pharmacokinetics of enteric coated ketoprofen: effect of cimetidine |
| Q93572872 | Single-dose and steady-state pharmacokinetics of piroxicam in elderly vs young adults |
| Q51686915 | Stereoselective interactions of ketoprofen glucuronides with human plasma protein and serum albumin |
| Q36053867 | Stereoselective pharmacokinetics of ketoprofen and ketoprofen glucuronide in end-stage renal disease: evidence for a 'futile cycle' of elimination |
| Q40536173 | Tenoxicam and renal function |
| Q36972832 | The Problems and Pitfalls of NSAID Therapy in the Elderly (Part II)1 |
| Q51703368 | The clinical pharmacokinetics of two different preparations of intrarectal Ketoprofen following spinal or local anesthesia for anal surgery |
| Q34418221 | The disposition of ketoprofen enantiomers in man |
| Q34346761 | The effects of age and gender on the pharmacokinetics of tenidap sodium in patients with rheumatoid arthritis and osteoarthritis |
| Q34345693 | The influence of renal function on the enantioselective pharmacokinetics and pharmacodynamics of ketoprofen in patients with rheumatoid arthritis. |
| Q39761044 | The pharmacokinetics of non-steroidal anti-inflammatory drugs in the elderly |
| Q41526041 | Toxicity of Nonsteroidal Anti-Inflammatory Drugs in the Elderly: Is Advanced Age a Risk Factor? |